These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 12074328)

  • 1. Mammographically detected breast cancers and the risk of axillary lymph node involvement: is it just the tumor size?
    Heimann R; Munsell M; McBride R
    Cancer J; 2002; 8(3):276-81. PubMed ID: 12074328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of women with T1-T2 breast cancer at low risk of positive axillary nodes.
    Fein DA; Fowble BL; Hanlon AL; Hooks MA; Hoffman JP; Sigurdson ER; Jardines LA; Eisenberg BL
    J Surg Oncol; 1997 May; 65(1):34-9. PubMed ID: 9179265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation of tumor size and axillary lymph node involvement with prognosis in patients with T1 breast carcinoma.
    Abner AL; Collins L; Peiro G; Recht A; Come S; Shulman LN; Silver B; Nixon A; Harris JR; Schnitt SJ; Connolly JL
    Cancer; 1998 Dec; 83(12):2502-8. PubMed ID: 9874455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of axillary dissection in mammographically detected carcinoma.
    Pandelidis SM; Peters KL; Walusimbi MS; Casady RL; Laux SV; Cavanaugh SH; Bauer TL
    J Am Coll Surg; 1997 Apr; 184(4):341-5. PubMed ID: 9100677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive factors associated with axillary lymph node metastases in T1a and T1b breast carcinomas: analysis in more than 900 patients.
    Rivadeneira DE; Simmons RM; Christos PJ; Hanna K; Daly JM; Osborne MP
    J Am Coll Surg; 2000 Jul; 191(1):1-6; discussion 6-8. PubMed ID: 10898177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Axillary lymph node staging in breast cancer by 2-fluoro-2-deoxy-D-glucose-positron emission tomography: clinical evaluation and alternative management.
    Greco M; Crippa F; Agresti R; Seregni E; Gerali A; Giovanazzi R; Micheli A; Asero S; Ferraris C; Gennaro M; Bombardieri E; Cascinelli N
    J Natl Cancer Inst; 2001 Apr; 93(8):630-5. PubMed ID: 11309439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Axillary node dissection in patients with breast cancer diagnosed through the Ontario Breast Screening Program: a need for minimally invasive techniques.
    Singhal H; O'Malley FP; Tweedie E; Stitt L; Tonkin KS
    Can J Surg; 1997 Oct; 40(5):377-82. PubMed ID: 9336528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is there a role for axillary dissection for patients with operable breast cancer in this era of conservatism?
    Chua B; Ung O; Taylor R; Boyages J
    ANZ J Surg; 2002 Nov; 72(11):786-92. PubMed ID: 12437688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term follow-up of axillary node-positive breast cancer patients receiving adjuvant systemic therapy alone: patterns of recurrence.
    Fisher BJ; Perera FE; Cooke AL; Opeitum A; Venkatesan V; Dar AR; Stitt L
    Int J Radiat Oncol Biol Phys; 1997 Jun; 38(3):541-50. PubMed ID: 9231678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complete axillary lymph node dissection for stage I-II carcinoma of the breast.
    Danforth DN; Findlay PA; McDonald HD; Lippman ME; Reichert CM; d'Angelo T; Gorrell CR; Gerber NL; Lichter AS; Rosenberg SA
    J Clin Oncol; 1986 May; 4(5):655-62. PubMed ID: 3701387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of axillary lymph node involvement in breast cancer patients with positron emission tomography using radiolabeled 2-(fluorine-18)-fluoro-2-deoxy-D-glucose.
    Avril N; Dose J; Jänicke F; Ziegler S; Römer W; Weber W; Herz M; Nathrath W; Graeff H; Schwaiger M
    J Natl Cancer Inst; 1996 Sep; 88(17):1204-9. PubMed ID: 8780629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer in the augmented breast. Diagnosis and prognosis.
    Clark CP; Peters GN; O'Brien KM
    Cancer; 1993 Oct; 72(7):2170-4. PubMed ID: 8374874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does information from axillary dissection change treatment in clinically node-negative patients with breast cancer? An algorithm for assessment of impact of axillary dissection.
    Dees EC; Shulman LN; Souba WW; Smith BL
    Ann Surg; 1997 Sep; 226(3):279-86; discussion 286-7. PubMed ID: 9339934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The benefits of mammography are not limited to women of ages older than 50 years.
    Heimann R; Bradley J; Hellman S
    Cancer; 1998 Jun; 82(11):2221-6. PubMed ID: 9610702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymphatic invasion, tumor size, and age are independent predictors of axillary lymph node metastases in women with T1 breast cancers.
    Gajdos C; Tartter PI; Bleiweiss IJ
    Ann Surg; 1999 Nov; 230(5):692-6. PubMed ID: 10561094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Axillary node metastasis from T1N0M0 breast cancer: possible avoidance of dissection in a subgroup.
    Iwasaki Y; Fukutomi T; Akashi-Tanaka S; Nanasawa T; Tsuda H
    Jpn J Clin Oncol; 1998 Oct; 28(10):601-3. PubMed ID: 9839499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Axillary lymph node dissection in clinically occult breast cancer].
    Le Bouëdec G; Pomel C; Chamussy E; Feillel V; de Latour M; Dauplat J
    Bull Cancer; 1996 Jul; 83(7):581-8. PubMed ID: 8868947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Percent positive axillary lymph node metastasis predicts survival in patients with non-metastatic breast cancer.
    Lale Atahan I; Yildiz F; Ozyigit G; Sari S; Gurkaynak M; Selek U; Hayran M
    Acta Oncol; 2008; 47(2):232-8. PubMed ID: 17924207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinically occult breast carcinoma: diagnostic approaches and role of axillary node dissection.
    Meterissian S; Fornage BD; Singletary SE
    Ann Surg Oncol; 1995 Jul; 2(4):314-8. PubMed ID: 7552620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics of Invasive Breast Cancer Detected by Digital Breast Tomosynthesis on Screening and Diagnostic Mammograms.
    Baydoun SE; Yang L; Xiong J; Fajardo LL
    Can Assoc Radiol J; 2021 May; 72(2):242-250. PubMed ID: 32062995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.